HTG Announces First Collaborator in Early Access Program for its Prototype Whole Transcriptome Panel
HTG Announces First Collaborator in Early Access Program for its Prototype Whole Transcriptome Panel HTG Announces First Collaborator in Early Access Program for its Prototype Whole Transcriptome Panel TUCSON, Ariz., Dec. 18, 2020 — HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that it has signed up the first collaborator in its recently announced Early Access Program for its prototype whole transcriptome panel. The Early Access Program is intended to allow select customers access to the panel in ...